Oxford Nanopore Technologies plc (LON:ONT – Get Free Report)’s stock price reached a new 52-week low on Thursday . The stock traded as low as GBX 105.60 and last traded at GBX 105.90, with a volume of 1492160 shares. The stock had previously closed at GBX 114.50.
Analyst Ratings Changes
Several analysts have recently weighed in on ONT shares. Deutsche Bank Aktiengesellschaft boosted their price target on Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the stock a “buy” rating in a report on Thursday, January 22nd. Royal Bank Of Canada dropped their price objective on shares of Oxford Nanopore Technologies from GBX 300 to GBX 225 and set an “outperform” rating for the company in a report on Tuesday, March 24th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 250 price objective on shares of Oxford Nanopore Technologies in a report on Thursday, January 22nd. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 218.60.
Get Our Latest Research Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Price Performance
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last announced its earnings results on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative return on equity of 29.43% and a negative net margin of 64.85%.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Recommended Stories
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
